Arsenic Trioxide for Leukemia TreatmentArsenic TrioxideHong Kong researchers developed ARSENOL?, the first oral arsenic trioxide drug for APL treatment, achieving over 97% survival. Approved by FDA & EMA, it's set to revolutionize leukemia care globally.
